We are live on
!
Find out more
Balyasny Asset Management Portfolio holdings
AUM
$77.1B
1-Year Est. Return
42.89%
This Fund
S&P 500
This Quarter
Est. Return
-12.87%
1 Year Est. Return
+42.89%
3 Year Est. Return
+126.29%
5 Year Est. Return
+172.74%
10 Year Est. Return
+1,026.86%
AUM
$13.9B
AUM Growth
-$8.15B
(-37%)
Cap. Flow
-$5.52B
Cap. Flow
% of AUM
-39.78%
Top 10 Holdings %
Top 10 Hldgs %
10.16%
Holding
2,006
New
392
Increased
427
Reduced
517
Closed
664
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dollar Tree
DLTR
|
+$107M |
| 2 |
Chubb
CB
|
+$107M |
| 3 |
FITB
Fifth Third Bancorp
FITB
|
+$91.9M |
| 4 |
Healthpeak Properties
DOC
|
+$90.9M |
| 5 |
Amazon
AMZN
|
+$86.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Wells Fargo
WFC
|
+$150M |
| 2 |
CenterPoint Energy
CNP
|
+$133M |
| 3 |
Equifax
EFX
|
+$132M |
| 4 |
RTX Corp
RTX
|
+$110M |
| 5 |
Regions Financial
RF
|
+$107M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 19.16% |
| 2 | Consumer Discretionary | 12.71% |
| 3 | Real Estate | 9.83% |
| 4 | Healthcare | 9.38% |
| 5 | Technology | 8.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1226
Ironwood Pharmaceuticals
IRWD
$668M
| $303K | ﹤0.01% |
+34,873
| New | +$400K |
|
|
CTRL
1227
DELISTED
Control4 Corporation
CTRL
| $303K | ﹤0.01% |
+17,229
| New | +$408K |
|
1228
Prestige Consumer Healthcare
PBH
$2.51B
| $301K | ﹤0.01% |
9,738
-221,039
| -96% | -$8.07M |
|
1229
Fluor
FLR
$7.3B
| $300K | ﹤0.01% |
+9,317
| New | +$402K |
|
1230
Encore Capital Group
ECPG
$2.01B
| $298K | ﹤0.01% |
+12,697
| New | +$341K |
|
1231
Onto Innovation
ONTO
$14.5B
| $296K | ﹤0.01% |
10,814
+4,637
| +75% | +$143K |
|
|
SGMO
1232
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $296K | ﹤0.01% |
+25,806
| New | +$321K |
|
1233
Rogers Communications
RCI
$18.7B
| $295K | ﹤0.01% |
5,762
+382
| +7% | +$19.8K |
|
1234
Under Armour
UAA
$2.5B
| $295K | ﹤0.01% |
+16,689
| New | +$343K |
|
1235
Louisiana-Pacific
LPX
$5.2B
| $293K | ﹤0.01% |
13,170
-59,324
| -82% | -$1.34M |
|
|
GTHX
1236
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $290K | ﹤0.01% |
+15,135
| New | +$567K |
|
|
CTLT
1237
DELISTED
CATALENT, INC.
CTLT
| $289K | ﹤0.01% |
9,253
-73,062
| -89% | -$2.82M |
|
1238
Matador Resources
MTDR
$6.49B
| $288K | ﹤0.01% |
+18,576
| New | +$467K |
|
|
ATH
1239
DELISTED
Athene Holding Ltd. Class A Common Shares
ATH
| $287K | ﹤0.01% |
7,207
-521,403
| -99% | -$23.5M |
|
1240
Loews
L
$23.3B
| $286K | ﹤0.01% |
6,290
-167,677
| -96% | -$7.9M |
|
1241
Sasol
SSL
$7.38B
| $279K | ﹤0.01% |
9,541
-26,709
| -74% | -$866K |
|
1242
WEC Energy
WEC
$34.6B
| $279K | ﹤0.01% |
4,022
-31,942
| -89% | -$2.24M |
|
1243
Clean Harbors
CLH
$16.4B
| $278K | ﹤0.01% |
5,630
-5,724
| -50% | -$357K |
|
1244
CRH
CRH
$67B
| $277K | ﹤0.01% |
+10,517
| New | +$298K |
|
1245
Aegon
AEG
$14B
| $272K | ﹤0.01% |
+68,362
| New | +$333K |
|
1246
Pacific Biosciences
PACB
$357M
| $271K | ﹤0.01% |
36,589
-436,767
| -92% | -$2.77M |
|
|
CJ
1247
DELISTED
C&J Energy Services, Inc.
CJ
| $271K | ﹤0.01% |
20,102
-61,493
| -75% | -$1.1M |
|
1248
Brady Corp
BRC
$4.54B
| $270K | ﹤0.01% |
+6,222
| New | +$259K |
|
|
FBC
1249
DELISTED
Flagstar Bancorp, Inc. New
FBC
| $270K | ﹤0.01% |
+10,225
| New | +$306K |
|
1250
Arbor Realty Trust
ABR
$1B
| $269K | ﹤0.01% |
+26,733
| New | +$311K |
|
Similar funds
CBU
BC
Balyasny Asset Management's Q4 2018 Portfolio in Review
As of Q4 2018, Balyasny Asset Management held 2,006 positions worth $13.9B, down 37% from $22B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Balyasny Asset Management withdrew a net $5.52B in Q4 2018, closing 664 positions and reducing 517 holdings. Its most notable exit was Equifax, an estimated $132M position sold in full.
By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Real Estate.
Against the trend, Balyasny Asset Management opened a new position in Aflac worth $83M.
- Balyasny Asset Management's largest Q4 2018 buy was Aflac: 1,821,849 shares worth $83M.
- Balyasny Asset Management added most to Dollar Tree in Q4 2018, an estimated $107M increase.
- Balyasny Asset Management's biggest Q4 2018 reduction was Wells Fargo, cutting an estimated $150M.
- Balyasny Asset Management fully exited Equifax in Q4 2018, selling an estimated $132M.
- Balyasny Asset Management's ten largest holdings make up 10% of its $13.9B portfolio in Q4 2018.
- Balyasny Asset Management opened 392 new positions and closed 664 in Q4 2018.
- Balyasny Asset Management's portfolio value fell 37% quarter-over-quarter to $13.9B.
Based on Balyasny Asset Management's 13F filing for Q4 2018, filed 14 Feb 2019.